Abstract
Until recently, it was generally assumed that the prevention of a significant proportion of osteoporotic fractures could only be achieved through the use of hormone replacement therapy soon after menopause. It is likely to be most cost-effective, however, if antifracture therapy could be undertaken among older, higher risk populations. Recent evidence suggests that there are a number of effective interventions that can be used among the over-65 age group, and the economic evidence supports the view that this is likely to be the best way forward for fracture prevention. (C) 1997, Elsevier Science Inc.
Original language | English |
---|---|
Pages (from-to) | 236-239 |
Number of pages | 4 |
Journal | Trends in Endocrinology and Metabolism |
Volume | 8 |
Issue number | 6 |
Publication status | Published - Aug 1997 |
Keywords
- HORMONE REPLACEMENT THERAPY
- COST-EFFECTIVENESS ANALYSIS
- BONE-MINERAL DENSITY
- HIP FRACTURE
- ELDERLY WOMEN
- POSTMENOPAUSAL OSTEOPOROSIS
- VITAMIN-D
- RISK
- ESTROGEN
- TRIAL